85 related articles for article (PubMed ID: 24584479)
1. HPV-related cervical disease and oropharyngeal cancer.
Lozza V; Pieralli A; Corioni S; Longinotti M; Bianchi C; Moncini D; Fallani MG
Arch Gynecol Obstet; 2014 Aug; 290(2):375-9. PubMed ID: 24584479
[TBL] [Abstract][Full Text] [Related]
2. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
3. Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study.
Christensen JT; Grønhøj C; Zamani M; Brask J; Kjær EKR; Lajer H; von Buchwald C
Acta Oncol; 2019 Mar; 58(3):267-272. PubMed ID: 30626248
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
6. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
Biron VL; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
Rietbergen MM; van Bokhoven AAJD; Lissenberg-Witte BI; Heideman DAM; Leemans CR; Brakenhoff RH; Bloemena E
Int J Cancer; 2018 Jul; 143(2):283-288. PubMed ID: 29441569
[TBL] [Abstract][Full Text] [Related]
8. [Ano-genital lesions due to human papillomavirus infection in women].
Heard I
Med Mal Infect; 2005 May; 35(5):302-5. PubMed ID: 15876506
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
11. Management of precancerous cervical lesions in iran: a cost minimizing study.
Nahvijou A; Sari AA; Zendehdel K; Marnani AB
Asian Pac J Cancer Prev; 2014; 15(19):8209-13. PubMed ID: 25339007
[TBL] [Abstract][Full Text] [Related]
12. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus infection and cervical dysplasia.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):853-7. PubMed ID: 23272541
[TBL] [Abstract][Full Text] [Related]
14. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
16. Clearance of human papillomavirus in women treated for cervical dysplasia.
Moore EE; Danielewski JA; Garland SM; Tan J; Quinn MA; Stevens MP; Tabrizi SN
Obstet Gynecol; 2011 Jan; 117(1):101-108. PubMed ID: 21173650
[TBL] [Abstract][Full Text] [Related]
17. Application of the Bethesda system of reporting for cervical cytology to evaluate human papilloma virus induced changes in oral leukoplakia, oral squamous cell carcinoma, and oropharyngeal squamous cell carcinoma: A cytomorphological and genetic study.
Sivakumar N; Narwal A; Kumar S; Kamboj M; Devi A; Pandiar D; Bhardwaj R
Diagn Cytopathol; 2021 Sep; 49(9):1036-1044. PubMed ID: 34165918
[TBL] [Abstract][Full Text] [Related]
18. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.
Fakhry C; Rosenthal BT; Clark DP; Gillison ML
Cancer Prev Res (Phila); 2011 Sep; 4(9):1378-84. PubMed ID: 21836021
[TBL] [Abstract][Full Text] [Related]
19. HPV positive tonsillar cancer in two laser surgeons: case reports.
Rioux M; Garland A; Webster D; Reardon E
J Otolaryngol Head Neck Surg; 2013 Nov; 42(1):54. PubMed ID: 24246045
[TBL] [Abstract][Full Text] [Related]
20. Preventing human papillomavirus disease.
Trimble CL
J Clin Oncol; 2012 Sep; 30(25):3037-8. PubMed ID: 22851562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
